Amedisys Inc.
AMED
Get informed when a big investor buys or sells
+ FollowCurrent Fair Value
11.7% upsideUndervalued by 11.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.32 Billion |
|---|---|
| Enterprise Value | $3.30 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $1.32 |
| Beta | 0.9 |
| Outstanding Shares | 32,849,000 |
Return
| Return on Equity | 12.75% |
|---|---|
| Return on Assets | 7.09% |
| Return on Invested Capital | 7.05% |
Valuation & Multiples
| P/E Ratio | 30.65 |
|---|---|
| PEG | 28.05 |
| Price to Sales | 1.38 |
| Price to Book Ratio | 2.66 |
| Enterprise Value to Revenue | 1.37 |
| Enterprise Value to EBIT | 27.09 |
| Enterprise Value to Net Income | 20 |
| Total Debt to Enterprise | 0.09 |
| Debt to Equity | 0.25 |
Revenue Sources
No data
Insider Trades
Institutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 31.7054▲ 774.00% |
|---|---|
| Total Calls | 78,400▲ 8.59% |
| Total Puts | 2,485,700▲ 43.66% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 100.46%▲ 3.68% |
|---|---|
| Total Invested | $3.25B▲ 10.42% |
| Investors Holding | 344▲ 18.00% |
ESG Score
No data
About Amedisys Inc.
CEO: Paul Kusserow Relevant Senate Committees
As the primary committee controlling taxation, entitlement spending, and Medicare pricing, it directly impacts Amedisys's revenue streams, profitability through tax policy, and overall market valuation.
This committee directly allocates federal spending, determining the 'precise cash flow' for programs like Medicare and Medicaid, which are primary revenue sources for home health care providers such as Amedisys.
This committee directly regulates labor laws, which significantly impact operational costs for service providers like Amedisys, and has broad oversight over health policy, directly affecting the company's legal and operational environment.